测试、跟踪和治疗控制严重急性呼吸综合征冠状病毒2的改善策略:印度的视角

IF 0.4 Q4 PHARMACOLOGY & PHARMACY Asian Journal of Pharmaceutics Pub Date : 2021-06-01 DOI:10.22377/ajp.v15i3.4142
N. Sharma
{"title":"测试、跟踪和治疗控制严重急性呼吸综合征冠状病毒2的改善策略:印度的视角","authors":"N. Sharma","doi":"10.22377/ajp.v15i3.4142","DOIUrl":null,"url":null,"abstract":"Ever since in January 2020, the WHO declared an international public health emergency, emerged as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease-19) pandemic which has devastated human race with its human-to-human transmission, mutation, and mortality with complex pathogenicity mechanism. Earlier theories postulated it to have emerged from “Wet Market,” Huanan Seafood Wholesale Market in Wuhan city of Hubei Province in China. Based on initial speculations, this pandemic was suggested to be of enzootic origin, considerably bats and pangolins as connecting link between human-animal transmissions, which were later refuted. Time bound and effective Test, Track, and Treat policy initiatives taken by Indian Government proved to be a benchmark in controlling the pandemic, up to certain extent. Molecular diagnostics have witnessed a scaled up trend in terms of reverse transcription polymerase chain reaction and Rapid Antigen Tests to detect the contagion in oro-pharyngeal and naso-pharyngeal swabs. It is imperative that frequent mutations in SARS-CoV-2 lead to development of new serotypes making screening for novel therapeutics or repurposing of drugs cumbersome. With an effort to consummate existing clinico-pharamaceutical gaps to curb SARS-CoV-2, ardent remains the fact that plants have been considered as medicinal power houses. Green therapeutics are formulation of active phyto components when administered, enhance the bio-availability through different drug delivery systems. Exploration of medicinal plants for their bio-active ingredients to develop immune-boosters as an antiviral prophylactic tool against SARS-CoV-2 remains a preferred choice among health-care practitioners, pharmacologists, and life sciences fraternity at large. In addition, indigenous vaccines have been granted approval for Emergency Use Authorization which would help lower the rates of transmission and mortality by significant numbers in times to come.","PeriodicalId":8489,"journal":{"name":"Asian Journal of Pharmaceutics","volume":null,"pages":null},"PeriodicalIF":0.4000,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Test, Track, and Treat Ameliorative Strategy to Contain Severe Acute Respiratory Syndrome Coronavirus 2: An Indian Perspective\",\"authors\":\"N. Sharma\",\"doi\":\"10.22377/ajp.v15i3.4142\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Ever since in January 2020, the WHO declared an international public health emergency, emerged as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease-19) pandemic which has devastated human race with its human-to-human transmission, mutation, and mortality with complex pathogenicity mechanism. Earlier theories postulated it to have emerged from “Wet Market,” Huanan Seafood Wholesale Market in Wuhan city of Hubei Province in China. Based on initial speculations, this pandemic was suggested to be of enzootic origin, considerably bats and pangolins as connecting link between human-animal transmissions, which were later refuted. Time bound and effective Test, Track, and Treat policy initiatives taken by Indian Government proved to be a benchmark in controlling the pandemic, up to certain extent. Molecular diagnostics have witnessed a scaled up trend in terms of reverse transcription polymerase chain reaction and Rapid Antigen Tests to detect the contagion in oro-pharyngeal and naso-pharyngeal swabs. It is imperative that frequent mutations in SARS-CoV-2 lead to development of new serotypes making screening for novel therapeutics or repurposing of drugs cumbersome. With an effort to consummate existing clinico-pharamaceutical gaps to curb SARS-CoV-2, ardent remains the fact that plants have been considered as medicinal power houses. Green therapeutics are formulation of active phyto components when administered, enhance the bio-availability through different drug delivery systems. Exploration of medicinal plants for their bio-active ingredients to develop immune-boosters as an antiviral prophylactic tool against SARS-CoV-2 remains a preferred choice among health-care practitioners, pharmacologists, and life sciences fraternity at large. In addition, indigenous vaccines have been granted approval for Emergency Use Authorization which would help lower the rates of transmission and mortality by significant numbers in times to come.\",\"PeriodicalId\":8489,\"journal\":{\"name\":\"Asian Journal of Pharmaceutics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2021-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Asian Journal of Pharmaceutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22377/ajp.v15i3.4142\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Pharmaceutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22377/ajp.v15i3.4142","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

自2020年1月世界卫生组织宣布进入国际公共卫生紧急状态以来,严重急性呼吸系统综合征冠状病毒(SARS-CoV-2)(冠状病毒病-19)大流行以其具有复杂致病机制的人际传播、突变和死亡给人类带来了毁灭性的打击。早期的理论认为它起源于中国湖北省武汉市的华南海鲜批发市场“湿市场”。根据最初的推测,这次大流行被认为是地方性动物病,主要是蝙蝠和穿山甲作为人与动物之间传播的联系纽带,后来被驳斥。事实证明,印度政府采取的有时限和有效的“检测、跟踪和治疗”政策举措在一定程度上是控制疫情的基准。分子诊断在逆转录聚合酶链反应和快速抗原检测方面呈扩大趋势,用于检测口咽和鼻咽拭子中的传染病。SARS-CoV-2的频繁突变必须导致新的血清型的发展,这使得筛选新疗法或重新利用药物变得困难。为了弥补现有的临床-制药差距,以遏制SARS-CoV-2,他仍然坚持将植物视为药用植物的事实。绿色疗法是活性植物成分的配方,当给药时,通过不同的药物传递系统提高生物利用度。探索药用植物的生物活性成分,开发免疫增强剂,作为对抗SARS-CoV-2的抗病毒预防工具,仍然是卫生保健从业者、药理学家和整个生命科学界的首选。此外,已批准土著疫苗的紧急使用授权,这将有助于在今后大大降低传播率和死亡率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Test, Track, and Treat Ameliorative Strategy to Contain Severe Acute Respiratory Syndrome Coronavirus 2: An Indian Perspective
Ever since in January 2020, the WHO declared an international public health emergency, emerged as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease-19) pandemic which has devastated human race with its human-to-human transmission, mutation, and mortality with complex pathogenicity mechanism. Earlier theories postulated it to have emerged from “Wet Market,” Huanan Seafood Wholesale Market in Wuhan city of Hubei Province in China. Based on initial speculations, this pandemic was suggested to be of enzootic origin, considerably bats and pangolins as connecting link between human-animal transmissions, which were later refuted. Time bound and effective Test, Track, and Treat policy initiatives taken by Indian Government proved to be a benchmark in controlling the pandemic, up to certain extent. Molecular diagnostics have witnessed a scaled up trend in terms of reverse transcription polymerase chain reaction and Rapid Antigen Tests to detect the contagion in oro-pharyngeal and naso-pharyngeal swabs. It is imperative that frequent mutations in SARS-CoV-2 lead to development of new serotypes making screening for novel therapeutics or repurposing of drugs cumbersome. With an effort to consummate existing clinico-pharamaceutical gaps to curb SARS-CoV-2, ardent remains the fact that plants have been considered as medicinal power houses. Green therapeutics are formulation of active phyto components when administered, enhance the bio-availability through different drug delivery systems. Exploration of medicinal plants for their bio-active ingredients to develop immune-boosters as an antiviral prophylactic tool against SARS-CoV-2 remains a preferred choice among health-care practitioners, pharmacologists, and life sciences fraternity at large. In addition, indigenous vaccines have been granted approval for Emergency Use Authorization which would help lower the rates of transmission and mortality by significant numbers in times to come.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Asian Journal of  Pharmaceutics
Asian Journal of Pharmaceutics PHARMACOLOGY & PHARMACY-
自引率
0.00%
发文量
47
期刊介绍: Character of the publications: -Pharmaceutics and Pharmaceutical Technology -Formulation Design and Development -Drug Discovery and Development Interface -Manufacturing Science and Engineering -Pharmacokinetics, Pharmacodynamics, and Drug Metabolism -Clinical Pharmacology, General Medicine and Translational Research -Physical Pharmacy and Biopharmaceutics -Novel Drug delivery system -Biotechnology & Microbiological evaluations -Regulatory Sciences
期刊最新文献
A Design of Experiment-based Approach for the Formulation Development and Evaluation of Repaglinide Transdermal Patch Using Natural Polymers Modification of Human Behavior due to Coronavirus Outbreak: A Brief Study on Current Scenario Formulation and Evaluation of Sustained Release Bilayer Tablets of Losartan Potassium Bioanalytical Method Development and Validation of Empagliflozin by LC–MS/MS Method and Quantitative Estimation of Drug Concentration in Human Plasma Formulation and Evaluation of Antidiabetic Polyherbal Tablets
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1